Re: New PP on Aug 13

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New PP on Aug 13

in response to

Re: New PP on Aug 13

RVXoldtimer

posted on Aug 20, 2019 10:22AM

Thats a nice vote of Confidence for the science from KD/ Eastern, as well as exercising the 5,000,000 RVX warrants at .75cents . Tells me Eastewrn likes what they see or hear so far and this late in the BETONMACE trial

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply